Jiangxi Provincial Cancer Hospital

This phase 3 trial tests whether adding toripalimab (an immunotherapy) to capecitabine (a chemotherapy pill) as maintenance therapy works better than capecitabine alone for people with high-risk nasopharyngeal carcinoma. The study enrolls 264 adults aged 18-70 who have completed …

This study tests a new treatment for nasopharyngeal cancer that has come back after initial therapy and cannot be surgically removed. The approach uses a special pattern of low and high dose radiation together with an immunotherapy drug (anti-PD-1) to shrink tumors, followed by s…

This study tests whether a topical chlorhexidine spray can prevent severe skin reactions caused by radiation therapy in people with nasopharyngeal cancer. About 148 participants will receive either the spray or a placebo during their radiation treatment. The goal is to see if the…